Although ATA has been amply evaluated in vitro, only few studies have assessed the activity of ATA in vivo, including its use as a curative agent against thrombosis (Strony et al., 1990), apoptosis (Roberts-Lewis et al., 1993; Heiduschka and Thanos, 2000), parasite infestations (Klein et al., 2008), bacterial (Y. pestis) (Liang et al., 2003), and Vaccinia virus (Smee et al., 2010) infections. Here, ATM is linked to parasitic infectious disease.